These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 30448598)

  • 61. Clinical impact of the early alanine amininotransferase flare during tenofovir monotherapy in treatment-naïve patients with chronic hepatitis B.
    Seo HY; Lee HA; Ko SY; Wang JH; Kim JH; Choe WH; Kwon SY
    Clin Mol Hepatol; 2017 Jun; 23(2):154-159. PubMed ID: 28479588
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Long-term growth and bone development in children of HBV-infected mothers with and without fetal exposure to tenofovir disoproxil fumarate.
    Wen WH; Chen HL; Shih TT; Wu JF; Ni YH; Lee CN; Zhao LL; Lai MW; Mu SC; Tung YC; Hsu HY; Chang MH;
    J Hepatol; 2020 Jun; 72(6):1082-1087. PubMed ID: 32044401
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Similar evolution of hepatitis B virus quasispecies in patients with incomplete adefovir response receiving tenofovir/emtricitabine combination or tenofovir monotherapy.
    Lavocat F; Dény P; Pichoud C; Al Hawajri N; Kitrinos K; Borroto-Esoda K; Zoulim F
    J Hepatol; 2013 Oct; 59(4):684-95. PubMed ID: 23742912
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Entecavir plus tenofovir combination therapy for chronic hepatitis B in patients with previous nucleos(t)ide treatment failure.
    Zoulim F; Białkowska-Warzecha J; Diculescu MM; Goldis AE; Heyne R; Mach T; Marcellin P; Petersen J; Simon K; Bendahmane S; Klauck I; Wasiak W; Janssen HL
    Hepatol Int; 2016 Sep; 10(5):779-88. PubMed ID: 27206517
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Tenofovir has inferior efficacy in adefovir-experienced chronic hepatitis B patients compared to nucleos(t)ide-naïve patients.
    Chung GE; Cho EJ; Lee JH; Yoo JJ; Lee M; Cho Y; Lee DH; Kim HY; Yu SJ; Kim YJ; Yoon JH; Zoulim F
    Clin Mol Hepatol; 2017 Mar; 23(1):66-73. PubMed ID: 28190329
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Antiviral Efficacy of Tenofovir Monotherapy in Children with Nucleos(t)ide-naive Chronic Hepatitis B.
    Choe JY; Ko JS; Choe BH; Kim JE; Kang B; Lee KJ; Yang HR
    J Korean Med Sci; 2018 Jan; 33(2):e11. PubMed ID: 29215820
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparison of the Efficacy of Tenofovir Versus Tenofovir plus Entecavir in the Treatment of Chronic Hepatitis B in Patients With Poor Efficacy of Entecavir: A Systematic Review and Meta-analysis.
    Chen J; Zhao SS; Liu XX; Huang ZB; Huang Y
    Clin Ther; 2017 Sep; 39(9):1870-1880. PubMed ID: 28797777
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hepatitis B virus wild-type and rtN236T populations show similar early HBV DNA decline in adefovir refractory patients on a tenofovir-based regimen.
    Svarovskaia ES; Curtis M; Zhu Y; Borroto-Esoda K; Miller MD; Berg T; Lavocat F; Zoulim F; Kitrinos KM
    J Viral Hepat; 2013 Feb; 20(2):131-40. PubMed ID: 23301548
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Development of tenofovir disoproxil fumarate resistance after complete viral suppression in a patient with treatment-naïve chronic hepatitis B: A case report and review of the literature.
    Cho WH; Lee HJ; Bang KB; Kim SB; Song IH
    World J Gastroenterol; 2018 May; 24(17):1919-1924. PubMed ID: 29740207
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Entecavir plus tenofovir versus entecavir plus adefovir in chronic hepatitis B patients with a suboptimal response to lamivudine and adefovir combination therapy.
    Park JG; Park SY
    Clin Mol Hepatol; 2015 Sep; 21(3):242-8. PubMed ID: 26523269
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Randomised clinical trial: 48 weeks of treatment with tenofovir amibufenamide versus tenofovir disoproxil fumarate for patients with chronic hepatitis B.
    Liu Z; Jin Q; Zhang Y; Gong G; Wu G; Yao L; Wen X; Gao Z; Huang Y; Yang D; Chen E; Mao Q; Lin S; Shang J; Gong H; Zhong L; Yin H; Wang F; Hu P; Xiao L; Li C; Wu Q; Sun C; Niu J; Hou J;
    Aliment Pharmacol Ther; 2021 Nov; 54(9):1134-1149. PubMed ID: 34587302
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Phase IIb multicentred randomised trial of besifovir (LB80380) versus entecavir in Asian patients with chronic hepatitis B.
    Lai CL; Ahn SH; Lee KS; Um SH; Cho M; Yoon SK; Lee JW; Park NH; Kweon YO; Sohn JH; Lee J; Kim JA; Han KH; Yuen MF
    Gut; 2014 Jun; 63(6):996-1004. PubMed ID: 23979965
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Long-term efficacy of tenofovir disoproxil fumarate therapy after multiple nucleos(t)ide analogue failure in chronic hepatitis B patients.
    Kim HJ; Cho JY; Kim YJ; Gwak GY; Paik YH; Choi MS; Koh KC; Paik SW; Yoo BC; Lee JH
    Korean J Intern Med; 2015 Jan; 30(1):32-41. PubMed ID: 25589833
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Short-term and long-term safety and efficacy of tenofovir alafenamide, tenofovir disoproxil fumarate and entecavir treatment of acute-on-chronic liver failure associated with hepatitis B.
    Li J; Hu C; Chen Y; Zhang R; Fu S; Zhou M; Gao Z; Fu M; Yan T; Yang Y; Li J; Liu J; Chen T; Zhao Y; He Y
    BMC Infect Dis; 2021 Jun; 21(1):567. PubMed ID: 34126939
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Long-Term Efficacy of Tenofovir Disoproxil Fumarate Therapy in Nucleos(t)ide-Experienced Chronic Hepatitis B Patients.
    Huang M; Jie Y; Lin G; Shi H; Li X; Li X; Wu Y; Chong Y
    Clin Drug Investig; 2016 Jun; 36(6):471-8. PubMed ID: 26992717
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Viral suppression and cirrhosis regression with tenofovir disoproxil fumarate in Asians with chronic hepatitis B.
    Tsai NC; Marcellin P; Buti M; Washington MK; Lee SS; Chan S; Trinh H; Flaherty JF; Kitrinos KM; Dinh P; Charuworn P; Subramanian GM; Gane E
    Dig Dis Sci; 2015 Jan; 60(1):260-8. PubMed ID: 25179493
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Tenofovir monotherapy versus tenofovir and entecavir combination therapy in patients with entecavir-resistant chronic hepatitis B with multiple drug failure: results of a randomised trial.
    Lim YS; Byun KS; Yoo BC; Kwon SY; Kim YJ; An J; Lee HC; Lee YS
    Gut; 2016 May; 65(5):852-60. PubMed ID: 25596179
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Management of Antiviral Resistance in Chronic Hepatitis B.
    Lim YS
    Gut Liver; 2017 Mar; 11(2):189-195. PubMed ID: 28183162
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Treatment Outcomes With First-line Therapies With Entecavir and Tenofovir in Treatment-Naive Chronic Hepatitis B Patients in a Routine Clinical Practice.
    Ha NB; Trinh HN; Rosenblatt L; Nghiem D; Nguyen MH
    J Clin Gastroenterol; 2016 Feb; 50(2):169-74. PubMed ID: 26018133
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Efficacy and safety of telbivudine and tenofovir disoproxil fumarate in preventing hepatitis B vertical transmission: A real-life practice.
    Liu J; Wang J; Yan T; Du D; Qi C; Cao F; Yao N; Yang Y; He Y; Tian Z; Ren D; Zhu L; Chen T; Zhao Y
    J Viral Hepat; 2019 Oct; 26(10):1170-1177. PubMed ID: 31177596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.